In This Article:
Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on Pico Far East Holdings Limited (HKG:752) due to its excellent fundamentals in more than one area. 752 is a notable dividend-paying company that has been able to sustain great financial health over the past. In the following section, I expand a bit more on these key aspects. For those interested in understanding where the figures come from and want to see the analysis, read the full report on Pico Far East Holdings here.
Excellent balance sheet average dividend payer
752's ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This indicates that 752 has sufficient cash flows and proper cash management in place, which is an important determinant of the company’s health. 752 appears to have made good use of debt, producing operating cash levels of 1.05x total debt in the prior year. This is a strong indication that debt is reasonably met with cash generated.
752 is also a dividend company, with ample net income to cover its dividend payout, which has been consistently growing over the past decade, keeping income investors happy.
Next Steps:
For Pico Far East Holdings, I've put together three key aspects you should look at:
-
Future Outlook: What are well-informed industry analysts predicting for 752’s future growth? Take a look at our free research report of analyst consensus for 752’s outlook.
-
Historical Performance: What has 752's returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
-
Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of 752? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.